Library / Laws / 115th Congress / House Bills / H.R. 4116
H.R. 4116
To amend the Public Health Service Act to require reporting by drug manufacturers to increase transparency in drug pricing, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2017-10-25 | 8.8K | ⠃⠗⠋ |